News

Home / News

TSH Biopharm was invited to attend the institutional investor conference hosted by Concord Securities

2023.3.7

...

More

TSH Board of Directors resolved to convene the 2023 Annual General Shareholders' Meeting

2023.2.24

...

More

TSH Board of Directors' Resolution on Distribution of 2022 Earnings

2023.2.24

...

More

TSH Board of Directors Approved Financial Statements For the Year Ended December 31, 2022

2023.2.24

...

More

Announcement of the Company's Acquisition of the Right-of-Use Assets From A Related Party

2022.12.22

...

More

TSH Board of Directors Approved Financial Statements For the Nine Months Ended September 30, 2022

2022.11.3

...

More